Lugano, Switzerland, 6 June 2024 – The
ESMO Gynaecological Cancers Congress 2024 will be held in Florence, Italy, between 20-22 June, hosting international experts who will present and discuss the latest developments in the biology, diagnosis and therapy of gynaecological tumours. The management of rare gynaecological malignancies will be among the key areas covered in the
scientific programme, available online.
The congress can be joined either in person or via the online platform.
Programme highlights
- Promising approach in the management of patients with rare gynaecological tumours within the European Reference Network for Rare Adult Solid Cancers (EURACAN).
- Encouraging results to transform the therapeutic landscape in advanced cervical cancer.
- Promising novel targets for ADC treatment in cervical and ovarian cancer.
- Related content: 24MO, Session on 22 June,10:20 - 11:50 CEST
- New genetic insights to provide personalised care in patients with gynaecological malignancies.
- Results of phase 3 studies in ovarian cancer.
Keynote Lecture
The results of 89 studies will be presented and published online as a supplement to
ESMO Open.
Press accreditation
ESMO welcomes press representatives working for recognised press outlets interested in obtaining information and reporting on cancer issues, upon presentation of a letter of assignment and a valid press card. Press representatives are required to observe and abide by the
ESMO Policy on Press Activities. To apply for press accreditation, please fill out the form available
here. Requests for press accreditation should be sent by
Wednesday, 19 June. Please be kindly informed that onsite press accreditation will not be possible.
Third Parties Media registration
Third Parties Media representatives and Filming Crews not eligible as press, must abide by the
ESMO Policy on Media Activities Organised by Third Parties and can request a Third Parties Media badge through registration@esmo.org (Cc media@esmo.org).
Further information
ESMO Press Office
press@esmo.org